How does jaundice occur in a child with Kawasaki disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How Jaundice Occurs in Kawasaki Disease

Jaundice in Kawasaki disease results from systemic inflammation affecting the liver and biliary system during the acute febrile phase, manifesting as hepatitis with elevated transaminases and/or cholestasis with gallbladder hydrops. 1

Pathophysiologic Mechanism

The underlying mechanism involves the widespread vasculitis characteristic of Kawasaki disease, which extends beyond coronary arteries to affect multiple organ systems including the hepatobiliary tract. 1

  • Hepatic inflammation occurs as part of the systemic inflammatory cascade, leading to hepatocellular injury and elevated liver enzymes 1
  • Biliary tract involvement can cause cholestatic jaundice, often accompanied by hydrops (distension) of the gallbladder 1, 2
  • The inflammation is driven by the same immune-mediated process causing arteritis throughout medium-sized vessels in the body 1

Clinical Presentation Patterns

Jaundice in Kawasaki disease typically presents in two forms:

  • Mild jaundice with modest transaminase elevation is a recognized associated finding in the standard presentation 1
  • Severe obstructive jaundice with cholestasis can occur as an atypical, jaundice-predominant presentation that may precede other classic features 3, 4

Associated Gastrointestinal Manifestations

The hepatobiliary involvement is part of broader gastrointestinal system inflammation: 1

  • Diarrhea, vomiting, and abdominal pain commonly accompany the jaundice 1
  • Gallbladder hydrops occurs in approximately 50% of jaundice-predominant cases 3
  • Pancreatitis may also be present 1
  • Some patients develop symptoms mimicking acute abdomen 2

Critical Clinical Implications

Children presenting with jaundice-predominant Kawasaki disease face significantly higher risks and require heightened vigilance: 3

  • IVIG-refractory disease occurs in 25-33% of jaundice-predominant cases compared to standard presentations 3
  • Coronary artery abnormalities develop in 25-58% of these patients 3
  • Shock complicates 13-25% of jaundice-predominant cases 3
  • Corticosteroid treatment is required more frequently (24-42%) due to IVIG resistance 3

Diagnostic Pitfalls to Avoid

The presence of prominent jaundice and hepatobiliary symptoms can delay diagnosis because: 4, 5

  • Fever with jaundice may initially be attributed to infectious hepatitis, metabolic disorders, or biliary obstruction 4
  • Classic mucocutaneous features may appear days to weeks after jaundice onset (sometimes not until day 8-13 of fever) 5
  • Gastrointestinal symptoms may lead to surgical admission with other Kawasaki features being overlooked 6
  • Persistent fever with jaundice of unknown origin should always prompt consideration of Kawasaki disease to prevent delayed treatment and coronary complications 4, 5

Laboratory Findings

When jaundice is present, expect: 1, 3

  • Elevated serum transaminases (hepatocellular pattern) 1
  • Direct hyperbilirubinemia in cholestatic presentations 7, 3
  • Standard Kawasaki disease markers: elevated ESR, CRP, leukocytosis with left shift, hypoalbuminemia 1
  • Thrombocytosis typically emerging in the second week 1

Genetic Considerations

Some evidence suggests that underlying Gilbert syndrome polymorphisms may predispose to more severe jaundice when Kawasaki disease develops, though this remains an area requiring further investigation. 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Kawasaki disease in children: epidemiology, clinical symptoms, diagnostics and treatment].

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2013

Research

Kawasaki disease presenting with hepatitis and prolonged fever: report of one case.

Acta paediatrica Taiwanica = Taiwan er ke yi xue hui za zhi, 2003

Guideline

Differential Diagnoses for Kawasaki Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the diagnosis for a 5-year-old child with fever, rash on the palms and soles, leukocytosis (high White Blood Cell (WBC) count), elevated erythrocyte sedimentation rate (SED rate), and thrombocytosis (high platelet count)?
What is the differential diagnosis for a patient presenting with hyperpyrexia (fever), strawberry tongue, and rash, without cough or conjunctivitis?
What are the symptoms and treatment of Kawasaki disease?
What are the symptoms and treatment of Kawasaki disease?
In a 49-year-old man who was treated for H. pylori–associated duodenal ulcer with omeprazole and a full course of eradication antibiotics and is now asymptomatic with a normal exam, what is the appropriate next step to confirm eradication?
In a patient with diabetes presenting with alternating diarrhea and constipation and generalized weakness, what is the differential diagnosis and immediate work‑up?
What does a high lactate dehydrogenase (LDH) level indicate?
What is the likelihood that an isolated pontine ischemic stroke would be completely negative on diffusion‑weighted imaging at symptom onset and remain negative on MRI performed four days later?
What are the dietary and supplemental sources of iodine for a typical adult?
In a male patient with generalized anxiety disorder on buspirone, slightly low serum testosterone, normal early‑morning erections, and no vascular risk factors, what is the most likely cause of his difficulty maintaining an erection: buspirone, hypogonadism, psychogenic, or vascular disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.